Delay to Tissue Plasminogen Activator in Hypertensive Stroke Patients: An Analysis of Delay Duration Across Agents
A subset of ischemic stroke patients present with blood pressures above that considered safe for thrombolytic administration, requiring antihypertensive therapy. Guideline statements are ambivalent regarding which antihypertensive agent should be used to obtain a satisfactory blood pressure
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Joseph F. Carrera, Brian J. Sorace, Bradford B. Worrall, Andrew M. Southerland, Nicole A. Chiota-McCollum Source Type: research